Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) is associated with diminished neuropsychological functioning. This randomized, double-blind, placebo controlled, study is the first comparison of two extended release stimulant-based medications (Adderall XR and Concerta) and placebo on ADHD neuropsychological functioning. Adolescents diagnosed with ADHD (n=35, 19 males) completed three separate assessments (5, 8, 11 p.m.) on three different days and medications (Concerta, Adderall XR and Placebo). The assessments consisted of two different neuropsychological tests, the Delayed Matching-to-Sample and the Go/No-go (GNG), which measure visual memory, attention span, and response inhibition. Results indicated a significant effect of medication on signs of impulsivity and memory. Simple contrasts showed significant improvement in neuropsychological functioning (as measured by commission errors, reaction time, and recall accuracy) when participants were taking Concerta as opposed to placebo. These results suggest that Concerta impacts not only symptomatic behaviors but also cognitive functioning, which has implications for both academic performance and daily functioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 2×
“ADHD has also been associated with a range of both verbal and nonverbal memory deficits (Castellanos & Tannock, 2002; Martinussen, Hayden, & Hogg-Johnson, 2005).”
BackgroundCastellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
MARTINUSSEN, R., HAYDEN, J., HOGG-JOHNSON, S., & TANNOCK, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153228.72591.73 · Cited by 1,297
sagvolden, T., johansen, E. B., aase, H., & russell, V. A. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000075 · Cited by 1,035
Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C. R., Simmons, A., & Bullmore, E. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.891 · Cited by 1,010
Rubia, K., Russell, T., Overmeyer, S., Brammer, M. J., Bullmore, E. T., Sharma, T., Simmons, A., Williams, S. C. R., Giampietro, V., Andrew, C. M., et al. (2001) · NeuroImage · doi:10.1006/nimg.2000.0685 · Cited by 999 · cited 2×
“…both reaction time and response inhibition and has been well supported in the literature as an effective measure for these cognitive processes (Shue & Douglas, 1992; Iaboni et al., 1995; Rubia et al., 1999a; Rubia et al., 1999b; Castellanos et al., 2000; Rubia et al., 2001a; Rubia et al., 2001b).”
BackgroundPsychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901
Filipek, P. A., Semrud-Clikeman, M., Steingard, R. J., Renshaw, P. F., Kennedy, D. N., & Biederman, J. (1997) · Neurology · doi:10.1212/wnl.48.3.589 · Cited by 732
The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder
Sergeant, J. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00060-3 · Cited by 645 · cited 2×
“…that the behavioral symptoms of ADHD are a consequence of a single underlying factor such as deficient inhibitory control (Barkley, 1998), state regulation deficits (Sergeant, 2000), or reinforcement-response abnormalities and motivational deficits (Sagvolden, Johansen, Aase, & Russell, in press).”
BackgroundGREENHILL, L. L., HALPERIN, J. M., & ABIKOFF, H. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00011 · Cited by 268
Cited by
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485
Illicit Use of Prescription ADHD Medications on a College Campus: A Multimethodological Approach
DeSantis, A. D., Webb, E. M., & Noar, S. M. (2008) · Journal of American College Health · doi:10.3200/jach.57.3.315-324 · Cited by 392
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Coghill, D. R., Seth, S., Pedroso, S., Usala, T., Currie, J., & Gagliano, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.005 · Cited by 271
Self-citationCoghill, D. R., Seth, S., & Matthews, K. (2014) · Psychological Medicine · doi:10.1017/s0033291713002547 · Cited by 242
“When given at 08:00 h, the effects on both cognition and driving performance lasted until 23:00 h whereas the effects on symptoms wore off (as expected) at around 20:00 h (Wilson et al. 2006).”
BackgroundSelf-citationAdvokat, C. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.03.006 · Cited by 219
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147
Self-citationJerome, L., Habinski, L., & Segal, A. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0045-8 · Cited by 130
Groom, M. J., Scerif, G., Liddle, P. F., Batty, M. J., Liddle, E. B., Roberts, K. L., Cahill, J. D., Liotti, M., & Hollis, C. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.029 · Cited by 101
The female side of pharmacotherapy for ADHD—A systematic literature review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239257 · Cited by 86
Tamminga, H. G. H., Reneman, L., Huizenga, H. M., & Geurts, H. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000350 · Cited by 82
“…71 (70) 10.1 (1.08)/9–12 – – WISC digit span and WRAML finger windowsc TOVA Backwards span Omissionshh 0.12 (0.17)u 0.36 (0.17)u Optimal Single challenge OROS, mean = 36.7 mg Wilson et al. (2006)aa,kk 35 (54) 17.5 (–)/16–19 6 0 GNG Commissions 0.30 (0.19) Fixed 17 days/condition OROS, 72 mg M…”
InfluentialDesantis, A., Noar, S. M., & Webb, E. M. (2010) · Journal of Drug Education · doi:10.2190/de.40.2.d · Cited by 71
Metadata
- Authors
- WILSON, H., COX, D., MERKEL, R., MOORE, M., & COGHILL, D.
- Venue
- Archives of Clinical Neuropsychology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-12
- Volume
- 21
- Issue
- 8
- Pages
- 797-807
- ISSN
- 0887-6177 (ISSN-L)
- OpenAlex
- W2020907811
- Cited by
- 55
- References
- 20
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.